About Estrellas Life Sciences
Estrellas Life Sciences is a company based in Ahmedabad (India) founded in 2017. It operates as a B2B. Estrellas Life Sciences offers products and services including Allopathic PCD Pharma Franchise, Skin Products, and Nutritional Products. Estrellas Life Sciences operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
- Headquarter Ahmedabad, India
- SectorsHealthcare
- Phone•••• ••••
- Website estrellaslifesciences.in
- Legal Name Estrellas Life Sciences Private Limited
- Date of Incorporation 18 Mar, 2013
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹19.63 Cr
FY 2025 · +8% YoY
- Net Profit₹1.31 Cr
FY 2025 · 7% margin
- EBITDA₹2.29 Cr
FY 2025 · 12% margin
Associated legal entities of Estrellas Life Sciences
Estrellas Life Sciences operates through Estrellas Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Estrellas Life Sciences Private Limited CIN U24239GJ2013PTC074048 | Active | 18 Mar 2013 | Ahmedabad, Gujarat | ₹19.6 Cr | – | 2 | View details |
Products & Services of Estrellas Life Sciences
Estrellas Life Sciences offers a comprehensive portfolio of products and services, including Allopathic PCD Pharma Franchise, Skin Products, and Nutritional Products.
Service for distributing pharmaceutical products via franchise
Creams and lotions for skin treatment and care
Vitamins and gummies for health enhancement
Board of directors of Estrellas Life Sciences Private Limited (Estrellas Life Sciences)
Estrellas Life Sciences Private Limited is the primary company behind Estrellas Life Sciences. The board of Estrellas Life Sciences Private Limited currently have 2 directors; the longest-serving is Shirish Mahendra Dave, appointed in 2013. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shirish Mahendra Dave DIN 06477000 | Director | 18 Mar 2013 | 13 yrs 6 mo | Estrellas Life Sciences Private Limited |
| Jay Shirishbhai Dave DIN 06476995 | Director | 18 Mar 2013 | 13 yrs 6 mo | Estrellas Life Sciences Private Limited |
Financials of Estrellas Life Sciences
Figures of Estrellas Life Sciences Private Limited, the primary company behind Estrellas Life Sciences, for FY 2025. Revenue was ₹19.63 Cr (+8% year on year). Net profit was ₹1.31 Cr (7% margin). EBITDA was ₹2.29 Cr (12% margin). Revenue has grown at a compounded annual rate of +8% over three years and +12% over five years.
- ₹19.63 CrRevenue · FY 2025 · +8% YoY
- ₹1.31 CrNet profit · 7% margin
- ₹2.29 CrEBITDA · 12% margin
- ₹21 LakhPaid-up capital
- +8%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Estrellas Life Sciences Private Limited are on its company page.
Detailed financial statements for Estrellas Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Estrellas Life Sciences
Estrellas Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $11.53M | 161 | Provider of medical equipment, devices, and drugs distribution services | |
| mahaveermedi.com | 2016 | Bengaluru, India | – | 588 | Serves as a distributor of a wide range of pharmaceutical drugs. | |
| dipnapharmachem.com | 2011 | Ahmedabad, India | – | – | Distributor of pharmaceutical raw materials |
Detailed competitors of Estrellas Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Estrellas Life Sciences
The website of Estrellas Life Sciences (estrellaslifesciences.in) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 53.1% vs previous month
Websites whose visitors overlap most with Estrellas Life Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| fibrofoods.com | 96% | – | – | View details |
Similar companies to Estrellas Life Sciences
10 companies that operate in the same segment as Estrellas Life Sciences (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Estrellas Life Sciences
Estrellas Life Sciences was founded in 2017.
Estrellas Life Sciences is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
The primary company behind Estrellas Life Sciences, Estrellas Life Sciences Private Limited, reported revenue of ₹19.63 Cr for FY 2025, up 8% year on year.
Estrellas Life Sciences Private Limited, based in Ahmedabad, India, manufactures and exports a variety of pharmaceutical products including allopathic medicines, skin care items, and nutritional supplements. They offer PCD Pharma Franchise services, providing monopoly rights and third-party manufacturing across India. With over 10 years of experience, they distribute tablets, syrups, and injections to serve healthcare needs nationwide, focusing on quality and certifications like GMP and ISO.
Estrellas Life Sciences's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
Estrellas Life Sciences offers Allopathic PCD Pharma Franchise, Skin Products, and Nutritional Products.
Estrellas Life Sciences operates through Estrellas Life Sciences Private Limited.
The legal entities of Estrellas Life Sciences currently have 2 directors, including Shirish Mahendra Dave, Jay Shirishbhai Dave.